Latest News

In two studies receiving international attention, 2013-16 BrightFocus grantee Rik Ossenkoppele, PhD, of Vrije Universiteit (VU) Medical Center, Amsterdam, and colleagues in the Netherlands have lent confidence to our understanding of how Alzheimer’s develops. Their findings help confirm that amyloid beta (Aβ) peptide levels start to build up and aggregate long before Alzheimer’s symptoms develop, and are predictive of disease.

The BrightFocus Foundation today honored seven outstanding scientists in the fields of macular degeneration and glaucoma, awarding them research grants named in honor of leaders in vision research and advocacy.

Gordon Legge of the University of Minnesota and Robert Massof of the Johns Hopkins Wilmer Eye Institute will today receive the prestigious 2015 Helen Keller Prize for Vision Research. The award is jointly presented by the Helen Keller Foundation for Research and Education and BrightFocus Foundation.

The Helen Keller Foundation for Research and Education and BrightFocus Foundation today announced that they will jointly present the prestigious Helen Keller Prize for Vision Research.

BrightFocus Foundation today announced $11 million in new research grant awards, a record amount for the non-profit in its efforts to cure diseases of mind and sight.

Targeting the growing rates of glaucoma and macular degeneration, the BrightFocus Foundation today launched a new Public Service Announcement (PSA) campaign, “Make a Plan Today: Get Your Eyes Checked.”

Being diagnosed with Alzheimer’s disease can be overwhelming, but the BrightFocus Foundation wants to help people take an active, informed role in their health care. In recognition of November’s Alzheimer’s Awareness Month, BrightFocus is offering a free, pocket-sized card of questions—available in English and Spanish—to bring to the doctor’s office.

BrightFocus Foundation extends its deepest sympathies to the family of Ben Bradlee. Mr. Bradlee, a giant in the field of journalism, leaves behind an historic, lasting legacy.

A pioneering online health study to assess the cognitive toll of Alzheimer’s and dementias caregiving using online brain performance tests was officially announced today at a ReACT/AARP event. Employers from more than 75 corporations, academic institutions, non-profits and government attended the event, which was held at AARP’s Washington, DC headquarters.

All of us involved with the fight to end Alzheimer’s disease were saddened to hear that Denver Broncos owner Pat Bowlen is stepping down from day-to-day control of the team to focus on his battle with this disease. For 30 years, Mr. Bowlen oversaw one of the most consistently successful teams in the National Football League (NFL).